Khalid Eljaaly

1.5k total citations
73 papers, 936 citations indexed

About

Khalid Eljaaly is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Khalid Eljaaly has authored 73 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 22 papers in Epidemiology and 20 papers in Infectious Diseases. Recurrent topics in Khalid Eljaaly's work include Antibiotic Use and Resistance (19 papers), Antibiotics Pharmacokinetics and Efficacy (19 papers) and Pneumonia and Respiratory Infections (14 papers). Khalid Eljaaly is often cited by papers focused on Antibiotic Use and Resistance (19 papers), Antibiotics Pharmacokinetics and Efficacy (19 papers) and Pneumonia and Respiratory Infections (14 papers). Khalid Eljaaly collaborates with scholars based in Saudi Arabia, United States and Egypt. Khalid Eljaaly's co-authors include Samah Alshehri, Jaffar A. Al‐Tawfiq, Aisha Alharbi, Jessica K. Ortwine, Abrar K. Thabit, Jason M. Pogue, Mushira A. Enani, Tarek S. Ibrahim, Brian L. Erstad and Wael A. H. Hegazy and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Khalid Eljaaly

67 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid Eljaaly Saudi Arabia 18 242 235 219 204 187 73 936
Yuichi Muraki Japan 17 119 0.5× 175 0.7× 236 1.1× 161 0.8× 382 2.0× 95 867
Katia Iskandar Lebanon 16 287 1.2× 169 0.7× 156 0.7× 79 0.4× 382 2.0× 55 1.1k
Paul M. Beringer United States 22 286 1.2× 333 1.4× 362 1.7× 500 2.5× 83 0.4× 64 1.4k
Lien Vo United States 15 199 0.8× 155 0.7× 143 0.7× 113 0.6× 152 0.8× 38 966
Katie K Tseng United States 9 207 0.9× 132 0.6× 172 0.8× 72 0.4× 372 2.0× 14 742
Diamantis P. Kofteridis Greece 16 288 1.2× 297 1.3× 262 1.2× 117 0.6× 195 1.0× 60 1.0k
Wesley D. Kufel United States 15 148 0.6× 231 1.0× 141 0.6× 239 1.2× 122 0.7× 64 640
Elizabeth Scicluna Malta 14 252 1.0× 267 1.1× 346 1.6× 159 0.8× 675 3.6× 22 1.1k
Christos Grigoras United States 12 331 1.4× 264 1.1× 281 1.3× 81 0.4× 351 1.9× 14 885
Tat Ming Ng Singapore 17 238 1.0× 110 0.5× 206 0.9× 161 0.8× 304 1.6× 37 654

Countries citing papers authored by Khalid Eljaaly

Since Specialization
Citations

This map shows the geographic impact of Khalid Eljaaly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Eljaaly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Eljaaly more than expected).

Fields of papers citing papers by Khalid Eljaaly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Eljaaly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Eljaaly. The network helps show where Khalid Eljaaly may publish in the future.

Co-authorship network of co-authors of Khalid Eljaaly

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Eljaaly. A scholar is included among the top collaborators of Khalid Eljaaly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Eljaaly. Khalid Eljaaly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thabit, Abrar K., et al.. (2025). A National Surveillance of the Antibiotic Susceptibility of Acinetobacter baumannii in Saudi Arabia. Antibiotics. 14(2). 209–209.
2.
Thabit, Abrar K., Khalid Al Sulaiman, Shuroug A. Alowais, et al.. (2025). Nitrofurantoin Versus Comparators in the Treatment of Cystitis due to Extended-Spectrum β-Lactamase–Producing Enterobacterales: A Multicenter Cohort Study. Annals of Pharmacotherapy. 59(9). 785–793.
3.
Khamis, Faryal, et al.. (2024). Intermittent hemodialysis: a review of the top antimicrobial stewardship practices to be employed. SHILAP Revista de lepidopterología. 4(1). e2–e2.
4.
Alshehri, Samah, et al.. (2023). Period Pain among Female University Students in Jeddah City, Saudi Arabia: Cross-Sectional Study. SHILAP Revista de lepidopterología. 50(2). 2 indexed citations
5.
6.
Langford, Bradley J., Kelly L. Matson, Khalid Eljaaly, et al.. (2022). Ten ways to make the most of World Antimicrobial Awareness Week. SHILAP Revista de lepidopterología. 2(1). e187–e187. 3 indexed citations
7.
Singh, Vanshikha, Khalid Eljaaly, Shadab Md, Nabil A. Alhakamy, & Prashant Kesharwani. (2022). Triblock copolymeric drug delivery as an emerging nanocarrier for treatment of infectious diseases. Journal of Drug Delivery Science and Technology. 75. 103691–103691. 15 indexed citations
8.
Thabit, Abrar K., et al.. (2022). Effectiveness of antimicrobial stewardship interventions on early switch from intravenous-to-oral antimicrobials in hospitalized adults: A systematic review. American Journal of Infection Control. 51(1). 89–98. 20 indexed citations
9.
Elfaky, Mahmoud A., Abrar K. Thabit, Khalid Eljaaly, et al.. (2022). Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica. Antibiotics. 11(11). 1585–1585. 22 indexed citations
10.
Ragab, Mahmoud, Khalid Eljaaly, Nabil A. Alhakamy, et al.. (2021). Deep Ensemble Model for COVID-19 Diagnosis and Classification Using Chest CT Images. Biology. 11(1). 43–43. 18 indexed citations
11.
Korayem, Ghazwa B., Hisham A. Badreldin, Khalid Eljaaly, et al.. (2021). Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacy. Saudi Pharmaceutical Journal. 29(11). 1343–1347. 21 indexed citations
12.
Eljaaly, Khalid, et al.. (2021). Efficacy of Empiric Antibiotic Coverage in Community-Acquired Pneumonia Associated with Each Atypical Bacteria: A Meta-Analysis. Journal of Clinical Medicine. 10(19). 4321–4321. 6 indexed citations
13.
Al-Rabia, Mohammed W., Nabil A. Alhakamy, Osama A. A. Ahmed, et al.. (2021). Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies. Pharmaceutics. 13(3). 307–307. 33 indexed citations
14.
Sulaiman, Khalid Al, Ohoud Aljuhani, Khalid Eljaaly, et al.. (2021). Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study. International Journal of Infectious Diseases. 105. 180–187. 34 indexed citations
15.
Alhakamy, Nabil A., Osama A. A. Ahmed, Tarek S. Ibrahim, et al.. (2021). Evaluation of the Antiviral Activity of Sitagliptin-Glatiramer Acetate Nano-Conjugates against SARS-CoV-2 Virus. Pharmaceuticals. 14(3). 178–178. 15 indexed citations
16.
Almangour, Thamer A., Abdullah A. Alhifany, Khalid Eljaaly, et al.. (2021). Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study. International Journal of Infectious Diseases. 108. 406–412. 15 indexed citations
17.
Al‐Tawfiq, Jaffar A., Hisham Momattin, Khalid Eljaaly, et al.. (2021). Antibiotics in the pipeline: a literature review (2017–2020). Infection. 50(3). 553–564. 61 indexed citations
18.
Alshehri, Samah, et al.. (2020). The impact of the first 24 h of loop diuretic on kidney function in acute decompensated heart failure. Irish Journal of Medical Science (1971 -). 190(3). 987–992. 4 indexed citations
19.
Monogue, Marguerite L., Jessica K. Ortwine, Wenjing Wei, Khalid Eljaaly, & Kavita Bhavan. (2018). Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia. Journal of Infection and Public Health. 11(5). 727–731. 20 indexed citations
20.
Eljaaly, Khalid, Samah Alshehri, Sandipan Bhattacharjee, Jaffar A. Al‐Tawfiq, & Asad E. Patanwala. (2018). Contraindicated drug–drug interactions associated with oral antimicrobial agents prescribed in the ambulatory care setting in the United States. Clinical Microbiology and Infection. 25(5). 620–622. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026